Ainos Inc
For the period ended Dec 31, 2024. Filed Mar 7, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 7, 2025
AIMD$0.47-21.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2024 and 2023
Balance Sheets
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $3,892,919 | $1,885,628 |
| Accounts receivable | 56 | 455 |
| Inventory, net | 143,756 | 167,593 |
| Other current assets | 301,077 | 419,521 |
| Total current assets | 4,337,808 | 2,473,197 |
| Intangible assets, net | 23,748,328 | 28,283,208 |
| Property and equipment, net | 559,645 | 876,572 |
| Other assets | 174,418 | 208,827 |
| Total assets | $28,820,199 | $31,841,804 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Contract liabilities | $106,329 | $112,555 |
| Convertible notes payable (including amounts of related party of $2,000,000 and nil as of December 31, 2024 and 2023, respectively) | 3,000,000 | - |
| Other notes payable, related party | - | 42,000 |
| Accrued expenses and other current liabilities | 848,615 | 1,182,283 |
| Total current liabilities | 3,954,944 | 1,336,838 |
| Senior secured convertible notes measured at fair value | - | 2,651,556 |
| Convertible notes payable - noncurrent (including amounts of related party of $9,000,000 and $2,000,000 as of December 31, 2024 and 2023, respectively) | 9,000,000 | 3,000,000 |
| Other notes payable, related party - noncurrent | - | 270,000 |
| Other long-term liabilities | 348,945 | 135,829 |
| Total liabilities | 13,303,889 | 7,394,223 |
| Commitments and contingencies | - | - |
| Stockholders’ equity: | ||
| Preferred stock, $0.01 par value; 50,000,000 shares authorized as of December 31, 2024 and 2023, respectively; none issued and outstanding | - | - |
| Common stock, $0.01 par value; 300,000,000 shares authorized as of December 31, 2024 and 2023; 15,427,385 shares and 4,677,787 shares issued and outstanding as of December 31, 2024 and 2023, respectively | 154,274 | 46,778 |
| Common stock to be issued, nil and 162,337 shares as of December 31, 2024 and 2023, respectively | - | 1,623 |
| Additional paid-in capital | 68,520,881 | 62,555,808 |
| Accumulated deficit | (52,749,316) | (37,886,155) |
| Accumulated other comprehensive loss - translation adjustment | (409,529) | (270,473) |
| Total stockholders’ equity | 15,516,310 | 24,447,581 |
| Total liabilities and stockholders’ equity | $28,820,199 | $31,841,804 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.